NAD+ Suppliers Compared 2026: The Quality Checklist You Need Before Ordering

## How to Choose a NAD+ Supplier: The Definitive Quality Checklist Choosing the right NAD+ supplier is the single most important decision affecting the safety and efficacy of your NAD+ therapy program. With the injectable NAD+ market growing rapidly in 2026, the gap between pharmaceutical-grade suppliers and low-quality operators has widened considerably. This guide provides a systematic, evidence-based framework for evaluating NAD+ suppliers -- covering purity testing, manufacturing standards, documentation, and the red flags that should make you walk away. Whether you are a clinic purchasing NAD+ for IV therapy, a practitioner sourcing injectable NAD+ for patients, or a researcher needing reliable material, this 12-point checklist will help you separate legitimate suppliers from those cutting corners. --- ## Why NAD+ Supplier Quality Matters More Than Most Peptides NAD+ (nicotinamide adenine dinucleotide) presents unique quality challenges that many other peptide and small molecule products do not: 1. **Thermolability**: NAD+ degrades significantly at room temperature. A 2019 study in *Scientific Reports* showed measurable potency loss within 48-72 hours at 25C. This means manufacturing, storage, and shipping conditions directly impact what you receive. 2. **Injectable route of administration**: Most clinical NAD+ is delivered via IV infusion or subcutaneous injection, making sterility, endotoxin levels, and particulate matter critically important. 3. **Dosing sensitivity**: Clinical NAD+ protocols use doses ranging from 100mg to 750mg+ per session. If purity is 85% instead of the stated 99%, patients receive substantially less active compound -- and potentially harmful impurities. 4. **No FDA-approved reference product**: Unlike semaglutide (where Novo Nordisk's Wegovy serves as a reference), there is no FDA-approved NAD+ injectable. This means the market relies entirely on supplier quality systems rather than regulatory oversight. --- ## The 12-Point NAD+ Supplier Quality Checklist ### 1. Certificate of Analysis (COA) -- Batch-Specific **What to look for:** A COA that is specific to the batch/lot number you are purchasing, not a generic document. **Red flag:** Supplier cannot provide a COA, or provides one that lacks a specific lot number, testing date, or laboratory name. **Verification step:** Ask for the COA before placing an order. Cross-reference the lot number on the COA with the lot number on the product label when it arrives. ### 2. HPLC Purity Testing **What to look for:** High-performance liquid chromatography (HPLC) results showing 98% purity or higher, ideally 99%+. The COA should include the actual chromatogram or at minimum the numerical purity result with the method reference. **Red flag:** Purity stated without specifying the testing method, or "purity" based on UV spectrophotometry alone (insufficient for NAD+). **Why it matters:** HPLC separates and quantifies each component in the sample. It is the gold standard for verifying that what you are buying is actually NAD+ and not a degradation product, precursor (like NMN or nicotinamide), or contaminant. ### 3. Endotoxin Testing (for Injectables) **What to look for:** Bacterial endotoxin testing results showing <0.25 EU/mL (USP standard for injectable products). The Limulus Amebocyte Lysate (LAL) test or recombinant Factor C (rFC) assay should be specified. **Red flag:** No endotoxin testing mentioned, or results significantly above USP limits. **Why it matters:** Endotoxins are pyrogens released from gram-negative bacteria. Even in a "sterile" product, endotoxin contamination can cause fever, chills, hypotension, and in severe cases, septic shock during IV infusion. ### 4. Sterility Testing **What to look for:** USP <71> sterility testing confirming no microbial growth after 14-day incubation. This applies to all injectable NAD+ products. **Red flag:** Supplier claims sterility based on filtration alone without confirming with a growth-based sterility test. ### 5. Third-Party Laboratory Testing **What to look for:** Testing performed by an independent, accredited laboratory -- not the manufacturer's in-house lab. Look for ISO 17025 accreditation of the testing facility. **Red flag:** All testing done in-house with no option for third-party verification. This does not automatically mean fraud, but it removes an important quality control layer. **Verification step:** Contact the named laboratory directly and ask them to confirm the COA is authentic. ### 6. cGMP Manufacturing Compliance **What to look for:** The supplier should manufacture or source from a facility that follows current Good Manufacturing Practice (cGMP) standards as defined by FDA 21 CFR Parts 210/211. Look for documentation of: - Written standard operating procedures (SOPs) - Environmental monitoring of cleanroom facilities - Equipment calibration records - Personnel training documentation - Deviation and CAPA (corrective and preventive action) systems **Red flag:** Supplier cannot name their manufacturing facility or provide evidence of GMP compliance. ### 7. Cold Chain Shipping and Storage **What to look for:** NAD+ shipped at 2-8C using insulated packaging with gel packs or dry ice. The supplier should specify storage conditions on the product label. **Red flag:** NAD+ shipped in a standard mailer without temperature control, especially during summer months. This almost guarantees degradation. | Shipping Method | Suitable for NAD+? | |---|---| | Insulated box + gel packs (2-8C) | Yes -- standard for short transit | | Dry ice shipping (-78C) | Yes -- best for multi-day transit | | Temperature-monitored packaging | Ideal -- confirms chain integrity | | Standard poly mailer | No -- unacceptable for injectable NAD+ | | Room temperature box | No -- degradation risk is high | ### 8. Proper Reconstitution and Handling Documentation **What to look for:** Clear instructions for reconstitution (if lyophilized), storage after reconstitution, and beyond-use dating. The supplier should specify compatible diluents (typically bacteriostatic water or sterile saline). **Red flag:** No handling instructions provided, or instructions that suggest room-temperature storage of reconstituted NAD+. ### 9. Transparent Business Registration and Contact **What to look for:** Verifiable business registration, physical address, and direct contact information. For US suppliers, check state business registration databases. The supplier should have a real customer service team, not just an email form. **Red flag:** PO Box only, no phone number, website registered anonymously, or inability to provide business registration details. ### 10. Consistent Batch-to-Batch Quality **What to look for:** Ask the supplier for COAs from multiple batches. Purity, appearance, and pH should be consistent. Significant variation suggests poor process control. **Red flag:** Purity swings of more than 1-2% between batches, or the supplier cannot provide historical COAs. ### 11. Appropriate Pricing **What to look for:** Pharmaceutical-grade injectable NAD+ at 500mg per vial typically ranges from $40-$80 wholesale. Prices significantly below this range should trigger scrutiny. **Red flag:** Pricing that seems too good to be true. Extremely low prices usually mean lower purity, inadequate testing, or improper manufacturing. You are not saving money if the product is degraded or contaminated. | Price Range (500mg vial, wholesale) | Quality Signal | |---|---| | $20-30 | Suspect -- verify all quality documentation carefully | | $40-60 | Typical for legitimate cGMP suppliers | | $60-80 | Premium segment, often includes enhanced testing | | $80+ | Verify you are not overpaying for marketing | ### 12. Regulatory Compliance and Adverse Event Reporting **What to look for:** The supplier should have a system for handling quality complaints and adverse event reports. They should also comply with DEA registration requirements if applicable to their product lines. **Red flag:** Supplier has no mechanism for reporting quality issues or adverse events, or dismisses the importance of post-market surveillance. --- ## Red Flags Checklist: Walk Away If You See These Use this quick-reference checklist to identify problematic NAD+ suppliers: - No batch-specific COA available - HPLC purity below 95% or not tested - No endotoxin testing for injectable products - No sterility testing documentation - Ships at room temperature without cold chain - Cannot name the manufacturing facility - No GMP documentation or facility audit reports - Anonymous website registration or PO Box only - Prices more than 40% below market average - No customer service phone number - Makes therapeutic claims that violate FDA regulations - Refuses to provide COAs before purchase If a supplier triggers 3 or more of these red flags, we strongly recommend looking elsewhere. --- ## How Prost Meets Every Criterion At Prost, our NAD+ products are designed to exceed each point on this checklist: | Criterion | Prost Standard | |---|---| | Batch-specific COA | Provided with every order; available pre-purchase on request | | HPLC purity | 99%+ consistently across all batches | | Endotoxin testing | <0.25 EU/mL per USP standards | | Sterility testing | USP <71> compliant, 14-day incubation | | Third-party testing | Independent ISO 17025 accredited lab | | cGMP manufacturing | FDA-registered, cGMP-compliant facility | | Cold chain shipping | 2-8C insulated packaging with temperature indicators | | Documentation | Full reconstitution guides, storage instructions, beyond-use dating | | Business transparency | US-registered LLC, direct phone and email support | | Batch consistency | <0.5% purity variation batch-to-batch | | Pricing | Competitive wholesale pricing with volume discounts | | Adverse event system | Formal complaint and AE reporting process | --- ## How to Verify a COA Is Real (Step-by-Step) 1. **Request the COA before ordering.** Any reputable supplier will provide this without hesitation. 2. **Check the lot/batch number.** It should be unique and match the labeling on your product. 3. **Verify the testing laboratory.** Search for the lab name online and confirm they are accredited. 4. **Look for the HPLC chromatogram.** A legitimate COA often includes the actual chromatographic trace, not just a number. 5. **Check the date.** Testing should be within the product's shelf life. A COA from 3 years ago is not relevant to today's batch. 6. **Contact the lab directly.** Call or email the testing laboratory and ask them to confirm the COA's authenticity using the batch number. 7. **Compare multiple batches.** If you order regularly, collect COAs over time. Consistency indicates good process control. --- ## The Bottom Line The NAD+ supplier market in 2026 ranges from pharmaceutical-grade operations with rigorous quality systems to fly-by-night operators selling untested product in uncontrolled conditions. The difference is not visible to the naked eye -- a vial of degraded NAD+ looks identical to a vial of 99% pure product. Your protection is documentation: batch-specific COAs, HPLC purity data, endotoxin and sterility results, cGMP compliance evidence, and cold chain verification. Use the 12-point checklist in this guide for every supplier you evaluate, and do not compromise on any of the critical criteria. Patient safety depends on it. --- ## References - [Stability of Nicotinamide Adenine Dinucleotide in Aqueous Solution](https://pubmed.ncbi.nlm.nih.gov/30653407/). *Scientific Reports*, 2019. - [NAD+ Metabolism and Its Roles in Cellular Processes](https://pubmed.ncbi.nlm.nih.gov/32929208/). *Nature Reviews Molecular Cell Biology*, 2021. - [FDA Guidance: Current Good Manufacturing Practice for Finished Pharmaceuticals](https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations). U.S. FDA, 2024. - [USP Chapter 797: Pharmaceutical Compounding - Sterile Preparations](https://www.usp.org/compounding/general-chapter-797). United States Pharmacopeia, 2023. - [Endotoxin Testing Requirements for Injectable Products](https://www.fda.gov/drugs/pharmaceutical-quality-resources/bacterial-endotoxinstoxins-pyrogens). U.S. FDA, 2023.